Among patients who survived a year since their last acute myocardial infarction (MI), subsequent major cardiovascular events, all-cause mortality and major bleeding risks are high.1,2 In unselected populations in USA, Sweden, England, and France, 20% of such patients experienced subsequent MI, stroke, or died during the following 3 years.2 Prolonged secondary prevention therapy in such patients is already recommended for four classes of drugs (statins, beta-blockers, ACE inhibitors, and...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lee
Contact Lee, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack